MojoKid writes "The PC demo for Codemasters' upcoming DirectX 11 racing title, Dirt 2, has just hit the web and is available for download. Dirt 2 is a highly-anticipated racing sim that also happens to feature leading-edge graphic effects. In addition to a DirectX 9 code path, Dirt 2 also utilizes a number of DirectX 11 features, like hardware-tessellated dynamic water, an animated crowd and dynamic cloth effects, in addition to DirectCompute 11-accelerated high-definition ambient occlusion (HADO), full floating-point high dynamic range (HDR) lighting, and full-screen resolution post processing. Performance-wise, DX11 didn't take its toll as much as you'd expect this early on in its adoption cycle." Bit-tech also took a look at the graphical differences, arriving at this conclusion: "You'd need a seriously keen eye and brown paper envelope full of cash from one of the creators of Dirt 2 to notice any real difference between textures in the two versions of DirectX."
Haven't read the review because it is "mostly spoiler free," which seems to me like manufacturing something that is "mostly carcinogenic free." If someone has a problem with spoilers, it's unlikely they're going to read the review on the off chance you've only spoiled the stuff they didn't care about and not the stuff they did.
eldavojohn writes: "A new drug developed is showing promising signs of reducing the risk of radiation death by almost 2/3. 5-androstenediol (AED), an adrenal gland hormone that stimulates marrow-cell growth will hopefully be something to use in emergency cases or in situations with a potential 'dirty bomb' to mitigate the amount of lives lost. From the article, "Amid growing fears of terrorist attacks with radioactive materials, the US government plans to award a contract for the treatment for acute radiation syndrome later this month under its revamped BioShield fund for civilian defences against chemical, biological and nuclear threats." An example of a capitalistic market at its finest or a result of over zealous terrorist fears?"